When we talk about GLP-1 medications, we’re usually focused on weight loss or the drug’s side effects (we’re looking at you, ...

A new study suggests semaglutide drugs like Ozempic, used for type 2 diabetes, may lower the risk of opioid overdose in ...

Medical researchers have found that people who take the semaglutide-based drugs Ozempic and Wegovy may be less likely to die ...

Semaglutide belongs to a class of prescription medications that mimic a hormone your body naturally produces after you eat. This hormone helps your pancreas make insulin, which lowers your blood sugar ...

Semaglutide was linked to a significantly lower risk of overdose than other antidiabetic drugs in patients with type 2 ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

A study of people with type 2 diabetes and opioid use disorder suggests that the key ingredient in Ozempic and Wegovy shows promise against addiction.

2:00 Semaglutide medication’s like Ozempic contribute to heart health, study finds Researchers studied 33,006 patients diagnosed with both Type 2 diabetes and opioid use disorder. Of these ...

Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...

For patients with type 2 diabetes and opioid use disorder, semaglutide is associated with a significantly lower risk for opioid overdose.

The Senate HELP Committee held a hearing to address the high cost of semaglutide drugs, finding that many patients cannot ...

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...